In 2015, Sonablate HIFU became the first focused ultrasound device to be FDA cleared in the US for the ablation of prostate tissue.
In 2015, Sonablate HIFU became the first focused ultrasound device to be FDA cleared in the US for the ablation of prostate tissue.
We are a global leader in focal therapy with over 30,000 patients treated worldwide.
Sonablate HIFU is approved in over 50 countries.
The Sonablate team has hundreds of combined years of experience with HIFU.
Our devices are proudly made in the USA.